A non-opioid option for withdrawal symptom management.
Alpha Eagle Technology is the authorized sales and marketing representative for BioCorRx Pharmaceuticals’ LUCEMYRA® (lofexidine), an FDA-approved prescription medication used in adults to help manage symptoms of opioid withdrawal.
LUCEMYRA is a non-opioid prescription medicine used in adults to help with symptoms of opioid withdrawal that may occur when an opioid is stopped suddenly. LUCEMYRA will not completely prevent opioid-withdrawal symptoms and is not a treatment for opioid use disorder.
A treatment option for a critical phase of care.
Withdrawal management can be an important first step in a patient’s recovery journey. LUCEMYRA gives healthcare professionals a non-opioid prescription option for helping adults manage opioid-withdrawal symptoms.
Alpha Eagle Technology works with healthcare and institutional partners to provide product education, answer questions and explore how LUCEMYRA may fit within established treatment protocols and patient-care initiatives.
FDA Approved
Approved for mitigation of opioid-withdrawal symptoms to facilitate abrupt opioid discontinuation in adults.
Non-Opioid
A prescription option that does not use an opioid to help manage withdrawal symptoms.
Adult Patients
Designed for use under appropriate medical supervision as part of a clinician-directed withdrawal-management plan.
Product education for teams across the continuum of care.
We welcome conversations with clinical and operational leaders evaluating evidence-based options for opioid-withdrawal symptom management.
Explore how LUCEMYRA may complement your current protocols.
Our team can provide an overview of the medication, respond to product questions and connect with the appropriate clinical or operational members of your organization.
Schedule a brief product discussion.
Tell us about your organization and the appropriate member of your team to contact.
Important Safety Information
What is LUCEMYRA? LUCEMYRA is a non-opioid prescription medicine used in adults to help with symptoms of opioid withdrawal that may occur when an opioid is stopped suddenly. It will not completely prevent withdrawal symptoms and is not a treatment for opioid use disorder.
Important risks
LUCEMYRA can cause serious side effects, including low blood pressure, slow heart rate and fainting. Patients should contact their healthcare provider if they experience dizziness, lightheadedness or fainting, and should avoid dehydration, overheating and standing too quickly. LUCEMYRA should be discontinued gradually because stopping it suddenly may increase blood pressure.
After a period without opioids, patients may become more sensitive to opioids. Resuming opioid use may increase the risk of overdose and death. Patients should tell their healthcare provider about heart, liver or kidney conditions; pregnancy or breastfeeding; alcohol use; and all medicines they take—especially benzodiazepines, barbiturates, tranquilizers or sleeping pills.
Common side effects
The most common side effects include low blood pressure or related lightheadedness, slow heart rate, dizziness, sleepiness and dry mouth.
To report suspected adverse reactions or product complaints, contact BioCorRx Pharmaceuticals Inc. at 1-833-LUCEMYRA. Suspected adverse reactions may also be reported to the FDA at 1-800-FDA-1088 or fda.gov/medwatch. Review the full Prescribing Information.
Rx only. LUCEMYRA® is a registered trademark of BioCorRx Pharmaceuticals Inc. This information is intended for U.S. audiences.